TY  - RPRT
TI  - A 52-week, multicenter, randomized, parallel-group, double-blind, double-dummy study to assess the efficacy of atorvastatin and simvastatin in reaching low-density lipoprotein cholesterol and triglyceride targets: the treat-to-target (3T) study.
AU  - Anders G Olsson
AU  - Mats Eriksson
AU  - Owe Johnson
AU  - Thomas Kjellström
AU  - Jan Lanke
AU  - Mogens Lytken Larsen
AU  - Terje Pedersen
AU  - Matti J Tikkanen
AU  - Olov Wiklund
AU  - 3T Study Investigators
PY  - 2003
DO  - 10.1016/s0149-2918(03)90015-4
UR  - https://pubmed.ncbi.nlm.nih.gov/12637115/
ID  - 12637115
ER  -